Zobrazeno 1 - 10
of 11
pro vyhledávání: '"K. W. Lo"'
Autor:
Y M, Lo, L Y, Chan, A T, Chan, S F, Leung, K W, Lo, J, Zhang, J C, Lee, N M, Hjelm, P J, Johnson, D P, Huang
Publikováno v:
Cancer research. 59(21)
Recently, cell-free EBV DNA has been detected in the plasma and serum of patients with nasopharyngeal carcinoma (NPC). We studied the relationship between plasma/serum EBV DNA and tumor recurrence. Using real-time quantitative PCR, the median plasma
Autor:
C T, Liew, H M, Li, K W, Lo, C K, Leow, W Y, Lau, L Y, Hin, B K, Lim, P B, Lai, J Y, Chan, X Q, Wang, S, Wu, J C, Lee
Publikováno v:
International journal of cancer. 81(3)
Hepatocellular carcinoma (HCC) is a common malignancy worldwide and highly associated with chronic virus-B or -C infection and cirrhosis. Molecular studies have shown high frequency of loss of heterozygosity (LOH) in some specific chromosome regions,
Publikováno v:
Journal of Histochemistry & Cytochemistry. 23:303-306
Publikováno v:
Surgical forum. 27(62)
Publikováno v:
Cancer. 50(2)
5'-nucleotide phosphodiesterase isozyme-V (5'-NPD-V) was evaluated in 85 biopsy proven breast cancer patients as a potential marker for early liver metastasis. It correctly predicts liver metastasis in 6/7 (85.7%) patients with abnormal radiologic li
Publikováno v:
Cancer research. 34(6)
Publikováno v:
Cancer chemotherapy reports. 57(3)
Publikováno v:
Cancer. 45(2)
2,131 coded sera were obtained and tested according to the new 5'-NPDase-V isozyme test. On decoding, 99/126 (79%) samples of primary hepatoma, from the United States and other countries, were positive. In the U. S. group, 51/58 (88%) were positive,
5'-Nucleotide phosphodiesterase isozyme-V as a marker for liver metastases in breast cancer patients
Publikováno v:
Cancer. 54(9)
A 2-year prospective study testing 258 breast cancer patients for the presence of 5'-nucleotide phosphodiesterase isozyme-V (5'-NPD-V) as a marker for liver metastases was undertaken. Despite the difficulty associated with such a study in obtaining d
Publikováno v:
Cancer research. 34(10)